BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Prognosis
12 results:

  • 1. Selectively targeting bcl6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
    Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
    Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene-Expression Profiling of Mucinous ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
    Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
    Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in ovarian cancer.
    Lu J; Zhen S; Tuo X; Chang S; Yang X; Zhou Y; Chen W; Zhao L; Li X
    Technol Cancer Res Treat; 2022; 21():15330338221110668. PubMed ID: 35770296
    [No Abstract]    [Full Text] [Related]  

  • 4. MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer.
    Rico SD; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; von Leffern I; Heilenkötter U; Jacobsen F; Bernreuther C; Clauditz T; Simon R; Steurer S; Burandt E; Marx AH; Krech T
    Pathol Res Pract; 2021 Aug; 224():153533. PubMed ID: 34171599
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mechanistically derived patient-level framework for precision medicine identifies a personalized immune prognostic signature in high-grade serous ovarian cancer.
    Zhao H; Gu S; Bao S; Yan C; Zhang Z; Hou P; Zhou M; Sun J
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32436954
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Non-Hodgkin´s B-lymphoma of the ovaries with an unfavourable prognosis - incidental finding during caesarean section].
    Kopáčková M; Beránek P; Bydžovská I; Pytlík R; Soukup J; Mrhalová M
    Ceska Gynekol; 2018; 83(1):45-49. PubMed ID: 29510639
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation].
    Imanaka R; Katayama Y; Iwato K; Kyo K; Okatani T; Itagaki M; Katsutani S; Asaoku H
    Rinsho Ketsueki; 2018; 59(1):58-63. PubMed ID: 29415939
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High expressions of bcl6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
    Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
    Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.
    Guo N; Peng Z
    J Ovarian Res; 2017 Mar; 10(1):14. PubMed ID: 28284216
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary follicular lymphoma of the fallopian tube found incidentally in a patient treated for endometrial carcinoma: a case report.
    Alduaij A; Hansen K; Zhang C
    Diagn Pathol; 2010 Jun; 5():44. PubMed ID: 20584306
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.
    Bamias A; Psaltopoulou T; Sotiropoulou M; Haidopoulos D; Lianos E; Bournakis E; Papadimitriou C; Rodolakis A; Vlahos G; Dimopoulos MA
    Cancer; 2010 Mar; 116(6):1462-8. PubMed ID: 20108307
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.
    Vang R; Medeiros LJ; Warnke RA; Higgins JP; Deavers MT
    Mod Pathol; 2001 Nov; 14(11):1093-9. PubMed ID: 11706069
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.